病毒样粒子纳米反应器:从催化到生物应用
Yuqing Su1, Beibei Liu1, Zhenkun Huang1
1Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China. aijieliu@xmu.edu.cn.
Journal of materials chemistry. B
|September 12, 2023
概括
病毒样粒子 (VLP) 是自然界的纳米载体,为先进的纳米反应器提供稳定,精确的结构. 本综述探讨了它们的催化应用和在生物医学中作为人工有机体的潜力.
科学领域:
- 生物技术和纳米技术
- 催化剂是一种催化剂.
- 生物医学工程 生物医学工程
背景情况:
- 病毒样粒子 (VLP) 是自然存在的,自组装的超分子结构.
- VLP具有有利的特性,如纳米级精度,单分散性和高稳定性.
- 这些特性使得VLP适合在各种应用中作为纳米载体使用.
研究的目的:
- 审查基于病毒样粒子 (VLPs) 的纳米反应器的当前进展.
- 探索用于催化应用的常见病毒颗粒的物理化学特性.
- 讨论VLP纳米反应器的自组装,它们作为人造器官的作用,以及潜在的生物医学用途.
主要方法:
- 基于VLP的纳米反应器的文献综述.
- 分析与催化相关的VLP物理化学性质.
- 关于VLP纳米反应器自组装和层次结构的概述.
主要成果:
- VLP 作为有效的纳米载体,保护和丰富催化剂,以改善反应.
- VLP纳米反应器提供了封闭的环境,防止散装溶液的干扰.
- 新兴的应用包括VLP纳米反应器作为人工有机体,具有潜在的生物医学相关性.
结论:
- 基于VLP的纳米反应器代表了催化和纳米技术的重大进步.
- 对VLP纳米反应器的进一步研究有望为新的生物医学应用提供希望.
- 该审查提供了对当前发现和该领域未来方向的见解.
相关概念视频
02:47Ribozymes
12.3K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
12.3K
01:29Subviral Agents
41
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
41